MAPT and Alzheimer disease: Neuron-based activity tests showed that AD-tau seeds that were amplified with recombinant T40 tau containing the pH-insensitive hylite488 fluorescent label (ADT40P1-h488) could induce mouse tau pathology like the parent AD-tau seeds (Fig. S9b).